Gene: PLA2G4F
Official Full Name: phospholipase A2 group IVFprovided by HGNC
Gene Summary: Predicted to enable calcium ion binding activity; calcium-dependent phospholipase A2 activity; and calcium-dependent phospholipid binding activity. Predicted to be involved in glycerophospholipid catabolic process. Predicted to act upstream of or within arachidonate secretion; cellular response to antibiotic; and prostaglandin biosynthetic process. Predicted to be located in mitochondrion and plasma membrane. Predicted to be active in cytosol; ruffle membrane; and vesicle. [provided by Alliance of Genome Resources, Jul 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA03617 | PLA2G4F Knockout cell line (AC16) | Human | PLA2G4F | 1:3-1:4 | negative | Online Inquiry |
| KOA19064 | PLA2G4F Knockout cell line (BEAS-2B) | Human | PLA2G4F | 1:3~1:4 | negative | Online Inquiry |
| KOA34514 | PLA2G4F Knockout cell line (U-2932) | Human | PLA2G4F | 1:2-1:4 | negative | Online Inquiry |
| KOA49917 | PLA2G4F Knockout cell line (TPC-1) | Human | PLA2G4F | 1:5-1:8 | negative | Online Inquiry |
| KOA65323 | PLA2G4F Knockout cell line (NCM460) | Human | PLA2G4F | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.